BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 17952764)

  • 21. Interaction of SR-4233 with hyperthermia and radiation in the FSaIIC murine fibrosarcoma tumor system in vitro and in vivo.
    Herman TS; Teicher BA; Coleman CN
    Cancer Res; 1990 Aug; 50(16):5055-9. PubMed ID: 2379171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyperthermic enhancement of the antitumor effect of natural human tumor necrosis factor-alpha and -beta: an in vitro and in vivo study.
    Maeda T; Fuchimoto S; Orita K
    Jpn J Cancer Res; 1988 Sep; 79(9):1054-61. PubMed ID: 3142836
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhancement of doxorubicin anti-cancer activity by vascular targeting using IsoDGR/cytokine-coated nanogold.
    Corti A; Sacchi A; Gasparri AM; Monieri M; Anderluzzi G; Colombo B; Gori A; Mondino A; Curnis F
    J Nanobiotechnology; 2021 May; 19(1):128. PubMed ID: 33952242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel tumor-derived mediator that sensitizes cytokine-resistant tumors to tumor necrosis factor.
    Marvin MR; Libutti SK; Kayton M; Kao J; Hayward J; Grikscheit T; Fan Y; Brett J; Weinberg A; Nowygrod R; LoGerfo P; Feind C; Hansen KS; Schwartz M; Stern D; Chabot J
    J Surg Res; 1996 Jun; 63(1):248-55. PubMed ID: 8661206
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Linkage with cathepsin B-sensitive dipeptide promotes the in vitro and in vivo anticancer activity of PEGylated tumor necrosis factor-alpha (TNF-α) against murine fibrosarcoma.
    Dai C; Fu Y; Li B; Wang Y; Zhang X; Wang J; Zhang Q
    Sci China Life Sci; 2011 Feb; 54(2):128-38. PubMed ID: 21318482
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Colloidal gold: a novel nanoparticle for targeted cancer therapeutics.
    Powell AC; Paciotti GF; Libutti SK
    Methods Mol Biol; 2010; 624():375-84. PubMed ID: 20217609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of tumor necrosis factor and hyperthermia on Meth-A tumors.
    Hiraoka M; Li YP; Tsutsui K; Abe M; Miyachi Y
    Jpn J Cancer Res; 1991 Oct; 82(10):1171-4. PubMed ID: 1955383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of sequencing of the total course of combined hyperthermia and radiation on the RIF-1 murine tumor.
    Mittal B; Emami B; Sapareto SA; Taylor FH; Abrath FG
    Cancer; 1984 Dec; 54(12):2889-97. PubMed ID: 6498765
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synergistic cytotoxic and antitumor effects of recombinant human tumor necrosis factor and hyperthermia.
    Watanabe N; Niitsu Y; Umeno H; Sone H; Neda H; Yamauchi N; Maeda M; Urushizaki I
    Cancer Res; 1988 Feb; 48(3):650-3. PubMed ID: 3335027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyperthermia and platinum complexes: time between treatments and synergy in vitro and in vivo.
    Kusumoto T; Holden SA; Ara G; Teicher BA
    Int J Hyperthermia; 1995; 11(4):575-86. PubMed ID: 7594810
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intravenous administration of polyethylene glycol-modified tumor necrosis factor-alpha completely regressed solid tumor in Meth-A murine sarcoma model.
    Tsutsumi Y; Kihira T; Tsunoda S; Kubo K; Miyake M; Kanamori T; Nakagawa S; Mayumi T
    Jpn J Cancer Res; 1994 Dec; 85(12):1185-8. PubMed ID: 7852179
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Augmented antitumour effects of combined treatment with hyperthermia and tumour necrosis factor on human gastric cancer xenotransplanted into nude mice.
    Fujimoto S; Konno C; Kobayashi K; Kokubun M; Shrestha RD; Kiuchi S; Takahashi M; Ohta M; Okui K
    Int J Hyperthermia; 1991; 7(3):511-8. PubMed ID: 1919146
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Efficacy of Radiation is Enhanced by Metformin and Hyperthermia Alone or Combined Against FSaII Fibrosarcoma in C3H Mice.
    Kim H; Kim D; Kim W; Kim E; Jang WI; Kim MS
    Radiat Res; 2022 Aug; 198(2):190-199. PubMed ID: 35930015
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyperthermia induces doxorubicin release from long-circulating liposomes and enhances their anti-tumor efficacy.
    Ning S; Macleod K; Abra RM; Huang AH; Hahn GM
    Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):827-34. PubMed ID: 8040030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment with the tumor necrosis factor-alpha-inducing drug 5,6-dimethylxanthenone-4-acetic acid enhances the antitumor activity of the photodynamic therapy of RIF-1 mouse tumors.
    Bellnier DA; Gollnick SO; Camacho SH; Greco WR; Cheney RT
    Cancer Res; 2003 Nov; 63(22):7584-90. PubMed ID: 14633671
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Schedule dependent tumour growth delay, DNA cross-linking and pharmacokinetic parameters in target tissues with cis-diamminedichloroplatinum(II) and etanidazole with or without hyperthermia or radiation.
    Teicher BA; Pfeffer MR; Alvarez Sotomayor E; Herman TS
    Int J Hyperthermia; 1991; 7(5):773-84. PubMed ID: 1834752
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antitumor activity of tumor necrosis factor alpha conjugated with divinyl ether and maleic anhydride copolymer on solid tumors in mice.
    Kaneda Y; Yamamoto Y; Kamada H; Tsunoda S; Tsutsumi Y; Hirano T; Mayumi T
    Cancer Res; 1998 Jan; 58(2):290-5. PubMed ID: 9443407
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interaction between adriamycin cytotoxicity and hyperthermia: growth-phase-dependent thermal sensitization.
    Urano M; Begley J; Reynolds R
    Int J Hyperthermia; 1994; 10(6):817-26. PubMed ID: 7884241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction with hyperthermia of tetrachloroplatinum(II)(Nile blue)2 and tetrachloroplatinum(II)(neutral red)2 in EMT6 murine cells and the murine FSaIIC fibrosarcoma.
    Herman TS; Teicher BA; Pfeffer MR; Khandekar VS; Korbut TT
    Cancer Res; 1990 Jul; 50(13):3826-31. PubMed ID: 2354434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of hyperthermia in regional alkylating agent chemotherapy.
    Abdel-Wahab OI; Grubbs E; Viglianti BL; Cheng TY; Ueno T; Ko S; Rabbani Z; Curtis S; Pruitt SK; Dewhirst MW; Tyler DS
    Clin Cancer Res; 2004 Sep; 10(17):5919-29. PubMed ID: 15355925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.